Journal article
Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size
Abstract
BACKGROUND: There is no consensus on a universal dosing method for calculating high-dose chemotherapy in allogeneic Stem Cell Transplant (SCT) patients. The Metropolitan Life (Met-Life) Insurance Company's weight-height tables have been used to determine body weight for chemotherapy dosing for SCT, however no formal study has been done to determine if the Met-Life weight- height tables can be used for chemotherapy dosing in SCT. We …
Authors
Sriharsha L; Lipton JH; Pond G; Ma C; Raybardhan S; Messner HA; Seki JT
Journal
Journal of Oncology Pharmacy Practice, Vol. 15, No. 4, pp. 201–210
Publisher
SAGE Publications
Publication Date
December 2009
DOI
10.1177/1078155208101960
ISSN
1078-1552
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdolescentAdultAntineoplastic Combined Chemotherapy ProtocolsBody WeightCombined Modality TherapyFemaleHumansLogistic ModelsMaleMiddle AgedNeoplasmsObesity, MorbidPredictive Value of TestsProportional Hazards ModelsReference StandardsRetrospective StudiesStem Cell TransplantationSurvival AnalysisTreatment OutcomeYoung Adult